Timing of Cholestyramine Doses in Cholestatic Liver Disease
The DOI matches its Crossref record.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Still being checked.
Cited by
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Management of primary biliary cirrhosis
Heathcote, J. E. (2000) · Hepatology · doi:10.1053/he.2000.5984 · Cited by 417
Pruritus in cholestatic and other liver diseases
Mela, M., Mancuso, A., & Burroughs, A. K. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01458.x · Cited by 129
Pruritus in Chronic Cholestatic Liver Disease
Bunchorntavakul, C., & Reddy, K. R. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.010 · Cited by 75
Palliative Care for Patients with End-Stage Liver Disease Ineligible for Liver Transplantation
Sánchez, W., & Talwalkar, J. A. (2006) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.12.007 · Cited by 58
Metadata
- Authors
- Javitt, N. B.
- Corresponding author
- Norman B. Javitt
- ORCID
- Norman B. Javitt
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1974-06-06
- Volume
- 290
- Issue
- 23
- Pages
- 1328-1329
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2416377533
- Cited by
- 23
- References
- 0
- Citations by year
- 2026: 1 · 2024: 1 · 2018: 1 · 2017: 1 · 2012: 1
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- cholestyramine, timing of drug administration, cholestatic liver disease, cholestasis, biliary obstruction
- MeSH terms
- Bile Acids and Salts, Cholestyramine Resin, Fasting, Humans, Liver Cirrhosis, Biliary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Timing of Cholestyramine Doses in Cholestatic Liver Disease. https://app.cochat.ai/papers/10.1056/nejm197406062902326
- The paper
- Javitt, N. B. (1974). Timing of Cholestyramine Doses in Cholestatic Liver Disease. New England Journal of Medicine. https://doi.org/10.1056/nejm197406062902326
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.